Summary. Recently, we described a leprechaun patient with a genetically transmitted severe insulin resistance due to the absence of functional insulin receptors as inferred from the loss of insulin binding to the patients' fibroblasts and the impaired autophosphorylation of the [~-chain of the receptor. This patient was homozygous for the genetic defect which was recently found to be a leucine to proline mutation at position 233 in the a-chain of the insulin receptor. In the present study we have examined insulin receptor functions in relatives of this patient. Some of these individuals are heterozygous for the genetic defect and have only one allele coding for a functional insulin receptor. Insulin binding to cultured fibroblasts from the heterozygous individuals is only 20-40% of control values indicating a Mendelian mode of inheritance of the binding defect. In contrast, insulin stimulated autophosphorylation of the [~-chain of the insulin receptor shows normal values, indicating compensation mechanisms operating on this process. The stimulation of the basal level of 2-deoxyglucose uptake by insulin in fibroblasts from the homozygous patient is 1.2 fold whereas the heterozygous and control individuals show stimulation values of approximately 1.65 ff)ld. Basal levels of 2-deoxyglucose uptake are similar in these fibroblasts. Oral glucose tolerance tests on the heterozygous individuals indicate an increased requirement for insulin of the target tissues as concluded from the tendency towards hyperinsulinaemia with no observed hyperglycaemia. The results show that individuals with a genetic lesion in the insulin receptor which leads to decreased insulin binding, have mild abnormalities in their glucose tolerance tests but do not seem to develop hyperglycaemia as seen in Type 2 (non-insulin-dependent) diabetes mellitus.
A variety of genetic defects may result in an impaired glucose homeostasis due to insulin resistance of the target tissues for insulin such as the liver, muscle and adipose tissue. The inherited syndromes of acanthosis nigricans type A and leprechaunism, which are characterized by an extreme resistance to insulin, are the result of mutations in the gene for the insulin receptor as indicated by recent data on molecular cloning of the insulin receptor DNA from these patients [1, 2] . Type 2 (non-insulin-dependent) diabetes mellitus, being a disease with a strong genetic component, is also characterized by insulin resistance of the target tissues. The genetic components involved in the predisposition to Type 2 diabetes are unknown and it seems possible that the disease is polygenic in nature, complicating the identification of the genes involved in the pathogenesis of the disease.
To investigate the effect of lesions in the insulin receptor gene on glucose homeostasis, we have examined insulin receptor functions and glucose tolerance in relatives from a leprechaun patient. This leprechaun patient is homozygous for a genetic defect in the insulin receptor which was recently found to be a leucine to proline mutation at position 233 in the receptor a-chain [3] . This defect is expressed as an almost complete absence of insulin binding to cultured fibroblasts and a severe decrease of insulin stimulated autophosphorylation of the [~-subunit of the insulin receptor [4] . The latter activity is thought to reflect the process of signal transduction [5, 61. Relatives from this patient, who are heterozygous for this mutation, have only one alMe coding for a functional insulin receptor, whereas the other allele codes for a non-functional receptor. Our data show that such a genetic pattern results in a marked decrease of insulin binding to cultured fibroblasts and a tendency of these individuals towards hyperinsulinaemia. None of these individuals showed hyperglycaemia, which is a characteristic of Type 2 diabetes mellitus. 
Subjects, materials and methods
The patient (leprechaun Geldennalsen) has been described previously [4] . Subject data are given in Table 1 . Subject numbers refer to the individuals given in the pedigree in Figure 1 . Informed consent was obtained. The Ethical Committee of the Faculty of Medicine of the University of Leiden has approved these studies.
Fibroblast culture
Fibroblasts were developed from explants of skin biopsies (forearm) from the leprechaun patient (470), his parents (329, 330) and three grandparents (326, 327, 328). Control fibroblasts were grown from six subjects (four males, two females), their ages ranging from 0 to 40 years. Cells were grown in F10 medium supplemented with 10% heat inactivated fetal calf serum in a 2.5% CO2 atmosphere.
Insulin binding, uptake of 2-deoxyglucose (2-DOG) and insulin stimulated autophosphorylation of the receptor
These assays were performed as described previously [4] .
Oral glucose tolerance test (OGTT)
After an overnight fast, blood was drawn for the determination of insulin and glucose concentrations. Subsequently, a 75 g oral glucose load was given and blood was drawn 30, 60, 90, 120, 150 and 180 min later for measurement of plasma glucose and insulin concentrations. Glucose was measured in whole blood using the continuous flow hexokinase method and insulin was measured by radioimmunoassay, as described previously [7] .
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Statistical analysis
Results are expressed as mean values+ SD for at least two independently performed experiments. Each of these experiments was performed in duplicate. Differences were evaluated by Student's t-test.
Results
The pedigree of the Geldermalsen family is shown in Figure 1 , indicating the consanguinity. The consanguinity suggests that the leprechaun patient (470) had a homozygous defect. This was recently confirmed by our finding of a homozygous leucine to proline mutation in the s-chain of the receptor. The parents of the patient (329 and 330) and the grandparents from the consanguineous line (327 and 328) were found to be heterozygous for the mutation. The grandfather (326) who maps outside the consanguineous line and 21 control individuals did not have this mutation [3] . The levels of a25I-insutin binding to fibroblasts from the members of this family are given in Figure 2 . Averaged binding data of insulin to fibroblasts from 6 healthy control subjects are also shown (C). The data indicate that the heterozygous carriers of the disease within this family (329, 330, 327, 328) have a severe reduction of insulin binding, whereas the non-cartier grandfather (326) has normal binding. Fibroblasts from the leprechaun patient lack a significant level of specific binding of insulin. As these binding data were obtained at low insulin concentrations (approximately 3.10,-11 tool/l), the results indicate that the number of high affinity insulin binding sites on the cell surface is decreased. The binding data on parents and grandparents are consistent with a Mendelian mode of inheritance of the binding defect. We have previously described [4] that an additional defect in the insulin receptor from this patient is a decrease in insulin stimulated autophosphorylation of the I~-chain of the insulin receptor. In view of this, we have also investigated this activity of the insulin receptor from the family members. Figure 3 shows the maximum levels of autophosphorylation at 10-6mol/1 insulin. Except for the patient, no significantly decreased activity of insulin stimulated autophosphorylation has been observed in the members of this family. It is unlikely that the normalization of l~-chain autophosphorylation is the result of an increased receptor number in the heterozygous carriers as mRNA levels for the insulin receptor are invariant in fibroblasts from these individuals. Also, cross-linking of t25I-insulin to the receptor using glycoprotein fractions from these fibroblasts gives similar yields of labelled a-chain (data not shown).
Another indicator of the functionality of the insulin receptor is the stimulation of 2-DOG uptake in fibroblasts by insulin (Fig. 4) . The insulin stimulated 2-DOG uptake by fibroblasts from the homozygous leprechaun patient (470) is 1.2 fold, whereas the heterozygous and control individuals show stimulation values of approximately 1.65 fold. The absolute levels of unstimulated 2-DOG uptake in these fibroblasts are given in the legend to Figure 4 . These data indicate that fibroblasts from the heterozygous individuals have no detectable decrease in insulin stimulated uptake of 2-DOG.
Besides in vitro investigation of the function of the insulin receptor, OGTT's were performed to obtain an impression about insulin action in vivo. Three heterozygous non-obese members of this family (327, 328, 329, ages 60, 69 and 29 years, respectively) were studied. Some characteristics of these individuals are given in Table1. Insulin and blood glucose levels were . The shaded area reflects the range in glucose and insulin levels of these control individuals. The diagnosis diabetes mellitus is given when glucose values rise above the glucose levels indicated in this figure by (,--,) [11] measured over a period of 180 min and the values were compared with data from a healthy non-obese control group [8] [9] [10] [11] 16] . The results are summarized in Figure 5 . A slightly disturbed OGTT is observed in these heterozygous individuals as indicated by a tendency toward hyperinsulinaemia with no observed hyperglycaemia. On the contrary, blood glucose level tended toward low-normal values.
Discussion
In this study we have investigated insulin receptor functions in vitro and insulin action in vivo in relatives from a previously described leprechaun patient [4] . This leprechaun patient has a severe insulin resistance which is caused by an almost complete absence of insulin binding to cultured fibroblasts and an impaired autophosphorylation of the [~-chain of the receptor. Because this patient is born from a consanguineous marriage it seemed likely that the genetic defect associated with the insulin resistance is homozygous in the patient and that the father, the mother and paternal as well as the maternal grandmother are heterozygous for the same mutation. We have recently characterized this mutation and shown that the patient is homozygous for a leucine to proline mutation at position 233 in the a-chain of the insulin receptor, whereas these family members are heterozygous for this mutation. Insulin binding was performed on fibroblasts from relatives of this patient and control subjects. The heterozygous relatives show insulin binding of only 20-40% of control values indicating a Mendelian mode of inheritance for the binding defect. The observation that individuals from the paternal and maternal line both show the insulin binding defect supports the homozygous nature of the defect in this patient. Studies on fibroblasts from other leprachaun patients, who are born from non-consanguineous relations and who are compound heterozygotes, also show an insulin binding defect [t2, 13] . These studies indicate however, that a different type of binding defect can be inherited from each parent. These observations correlate with the finding that leprechaun Geldermalsen is indeed homozygous for the defect in insulin receptor function and that the heterozygous individuals from this family have only one allele coding for a functional receptor.
The autophosphorylation of the insulin receptor at tyrosine residues is considered to reflect the receptors' activity for signal transduction which results in enhanced glucose uptake [5, 6] . Quantitating the autophosphorylation activity in heterozygous carriers is another way of investigating the mode of inheritance of the receptor malfunction found in the patient. Within this family none of the individuals showed a singificantly decreased autophosphorylation of the receptor after insulin stimulation. No decrease of insulin stimulated 2-DOG uptake was detected in cultured fibroblasts from this family either, confirming the role of autophosphorylation in the insulin stimulated glucose uptake. The autophosphorylation activity apparently overcomes the binding defect.
It should be emphasized, however, that the 2-DOG assay using fibroblasts is not sensitive enough to detect small variations in hexose uptake due to the large SD's. Thus, it is also possible that subtle differences in glucose uptake are not detected in our tests. Because the heterozygous individuals show a reduced insulin binding on their cultured fibroblasts we suppose that compensation mechanisms acting at the level of autophosphorylation are involved in maintaining a more or less normal glucose uptake. The insulin stimulated autophosphorylation of the insulin receptor is regulated by different factors, such as calcium-activated and phospholipid-dependent protein kinase C [15] . Consequently, there may exist a population of receptors active in autophosphorylation and an inactive receptor population and the ratio between these populations may vary depending on regulatory feed-back processes. The normalisation of the insulin stimulated receptor autophosphorylation seems unable to fully compensate for the insulin binding defect in the heterozygous individuals as the OGTT tests indicate a tendency toward hyperinsulinaemia. The resulting glucose levels, however, are almost normal. These data agree with a situation in which the target tissues, as a result of a decreased number of functional insulin receptors, require elevated insulin concentrations for glucose disposal. On the other hand, the pancreas responds in such a way to the glucose level that a more or less normal glucose homeostasis can be maintained.
Genetic factors involved in the genesis of milder forms of insulin resistance such as Type 2 diabetes mellitus are unknown. ~[he OGTT data on the heterozygous individuals indicate that a genetic make-up which leads to a decrease in the number of functional insulin receptors is not sufficient for the development of Type 2 diabetes mellitus. Two of these individuals are 60 and 69 years old. At that age a genetic predisposition for Type 2 diabetes is likely to manifest itself by high blood glucose levels during OGTT [11] . None of the three tested heterozygous relatives showed such an abnormality, in contrast blood glucose levels tended toward low values, with elewLted insulin levels. As a binding defect alone seems insufficient to develop Type2 diabetes, other or additional factors must be involved in the development of Type 2 diabetes mellitus. One of these factors may be the tyrosine kinase activity of the insulin receptor. An acquired decrease in this activity is often observed in Type 2 diabetes [8, 14] . In the heterozygous individuals studied in this paper, no indication for a decreased activity is observed. In contrast, the in vitro experiments indicate that this activity even seems to compensate for the decreased level of insulin binding. Other studies have suggested that in addition to insulin resistance of' the periphery an insufficient in-sulin production by the pancreas is involved in the development of Type 2 diabetes mellitus [17] . The pancreases of the individuals studied here seemed quite responsive to an increase in blood glucose levels.
Also, variations in the glucose transporter function may be an additional factor that is involved in this disease [18] . Studies of other patients with extreme insulin resistance may help to identify additonal genetic factors involved in the pathogenesis of the several forms of insulin resistance. This may give insight into those factors specifically involved in the genesis of Type 2 diabetes mellitus.
